Register today for the fifth joint BIA and MHRA
conference Pathway of Innovation from Research to Patients, taking place on Thursday 11 June at the
Wellcome Trust in London.
and speakers are now confirmed for this must-attend one-day conference which
will provide the opportunity to showcase the collaborative approach between
stakeholders to support innovation and facilitate clinical development and
timely access to new treatments and vaccines.
Full programme details
can be found on the conference
informative keynote presentation on patient access to innovative therapies and
technologies from Professor Sir Michael Rawlins, Chairman, Medicines and
Healthcare products Regulatory Agency, will kick-off the conference.
conference will be the ideal place to hear the very latest thinking from senior
experts and leading speakers from the MHRA and National Institute for
Biological Standards and Control (NIBSC), the life science industry, the
Wellcome Trust, the Jenner Institute and patient organisations on topics
involvement in regulatory decision-making and drug development
MHRA post-merger: this session will focus on advanced therapy medicinal
products promise and progress, standardisation of biosimilars and
development of assays for immunogenicity
regulatory approvals and processes case study: response against the
ebola virus disease from bench science to clinical research, lessons
learnt and applicability to other therapeutic areas
registration fee for an MHRA contact is 395.00 + VAT
If your organisation is a BIA member the system will
recognise your domain address and automatically show you the correct member
rate for your place at the conference.
If your organisation is not a BIA member, please use the
voucher code MHRA1106 during the registration process to claim your 100
+ VAT discount on the non-member rate.
contact Cathrine Smyth (CSmyth@bioindustry.org)
if you have any questions regarding registration.